首页> 外文期刊>Molecules >Pharmacokinetic Comparison of Scutellarin and Paeoniflorin in Sham-Operated and Middle Cerebral Artery Occlusion Ischemia and Reperfusion Injury Rats after Intravenous Administration of Xin-Shao Formula
【24h】

Pharmacokinetic Comparison of Scutellarin and Paeoniflorin in Sham-Operated and Middle Cerebral Artery Occlusion Ischemia and Reperfusion Injury Rats after Intravenous Administration of Xin-Shao Formula

机译:黄cut苷和S药苷在深静脉手术和中脑梗塞缺血再灌注大鼠静脉给药后的药动学比较

获取原文
           

摘要

Xin-Shao formula is a folk remedy widely used in China to prevent and cure stroke. Cerebral ischemic reperfusion (I/R) injury often takes place during the treatment of stroke. Information about the pharmacokinetic behavior of the remedy under cerebral I/R injury conditions is lacking. The present study aimed to compare the pharmacokinetic properties of scutellarin and paeoniflorin, two major bioactive components of Xin-Shao formula, under physiological state in cerebral I/R injury rats. Neurobehavioral dysfunction was evaluated and cerebral infarcted volume was measured in middle cerebral artery occlusion I/R injury (MCAO) rats. Plasma samples were collected at various time points after a single dose (intravenous, i.v.) of Xin-Shao formula. The levels of plasma scutellarin and paeoniflorin at the designed time points were determined by a UPLC-MS/MS method, and drug concentration versus time plots were constructed to estimate pharmacokinetic parameters. Increase in terminal elimination half-life (t1/2z) and mean residence time (MRT(0–t)) of scutellarin as well as elevation in area under the plasma drug concentration-time curve from 0 h to the terminal time point (AUC(0–t)) and maximum plasma drug concentration (Cmax) of paeoniflorin, along with decreased clearance of paeoniflorin and scutellarin as well as reduced apparent volume of distribution (Vz) of paeoniflorin, were observed in MCAO rats, compared with those in sham-operated animals. The elimination of scutellarin and paeoniflorin were reduced in cerebral I/R injury reduced rats. View Full-Text
机译:新少方是在中国广泛用于预防和治疗中风的民间疗法。脑缺血再灌注(I / R)损伤通常发生在中风治疗期间。缺乏有关在脑I / R损伤情况下该药物的药代动力学行为的信息。本研究旨在比较在生理状态下脑缺血再灌注损伤大鼠中新-配方的两个主要生物活性成分-黄cut苷和pa药苷的药代动力学特性。评估了大脑中动脉闭塞I / R损伤(MCAO)大鼠的神经行为功能障碍并测量了脑梗死体积。单次(静脉内,静脉注射)新少配方奶粉后的不同时间点收集血浆样品。通过UPLC-MS / MS方法确定设计时间点的血浆黄cut苷和pa药苷水平,并建立药物浓度与时间的关系图以估算药代动力学参数。从0 h到最终时间点(AUC),黄cut素的最终消除半衰期(t1 / 2z)和平均停留时间(MRT(0–t))的增加以及血浆药物浓度-时间曲线下面积的增加与假手术组相比,在MCAO大鼠中观察到pa药苷的最大浓度(0-t)和最大血浆药物浓度(Cmax),以及clearance药苷和黄cut苷的清除率降低以及apparent药苷表观分布体积(Vz)降低。的动物。在减轻大脑I / R损伤的大鼠中减少了黄rin苷和pa药苷的消除。查看全文

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号